Close
Innovative Solutions and Cutting-Edge Technologies Take Centre Stage at Water Expo Delhi 2024 Jun 1, 2024 10:30AM

Chennai, Tamil Nadu Jun 1, 2024 (Issuewire.com) - Water Today's Water Expo Delhi 2024, the premier event in the water technology and management sector, is set to open its doors from 28 to 30 August 2024 at the ITPO Hall 12 A, Pragati Maidan, New Delhi, showcasing the latest innovations, sustainable practices, and cutting-edge technologies in the water industry. Organized by Water Today Pvt Ltd, this year's expo promises to be the most comprehensive and impactful edition... (continue reading...)


Revolutionizing Sustainability: The Environment Protection Technologies Expo Jun 1, 2024 10:28AM

New Delhi, Delhi Jun 1, 2024 (Issuewire.com) - Environment Protection Technologies Expo Delhi (EPTEX) an initiative by Water Today is thrilled to announce the inaugural Expo in New Delhi, set to take place from 28 to 30 August 2024 at the ITPO Hall 12 A, Pragati Maidan, New Delhi. This groundbreaking event will showcase the latest advancements in environmental protection technologies, bringing together industry leaders, innovators, policymakers, and environmental... (continue reading...)


Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC Jun 1, 2024 09:30AM

CHICAGO--(BUSINESS WIRE)-- Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker testing for patients with non-small cell lung cancer (NSCLC). The magnitude and frequency of updates to oncology guidelines each year make it difficult for the updates to be rapidly... (continue reading...)


Postmedia Announces Closing of Previously Announced Transaction with the Klein Group Jun 1, 2024 09:15AM

TORONTO--(BUSINESS WIRE)-- Postmedia Network Inc., a wholly owned subsidiary of Postmedia Network Canada Corp. (“Postmedia” or “the Company”) today announced that it has closed its previously announced sale of the Winnipeg Sun, The Graphic Leader, Kenora Miner & News and the Winnipeg Press Commercial Print division to the Klein Group Ltd. (the “Klein Group”).

About Postmedia Network Canada Corp.

Postmedia Network Canada Corp. (TSX:PNC.A, PNC.B) is... (continue reading...)


Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing Jun 1, 2024 09:14AM

NASSAU, The Bahamas, June 01, 2024 (GLOBE NEWSWIRE) -- OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for June 1, 2024.

OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures ListingIn a continuous effort to enhance market liquidity and mitigate risks, OKX has announced that it will be making adjustments to the position tiers of its TURBO/USDT perpetual futures listing.

This action... (continue reading...)


More Press Releases

View Older Stories

Jun 1, 2024 09:00AM Fungies Mushroom Gummies Announces Major Retail Expansion and Availability at Walmart
Jun 1, 2024 09:00AM Vincent Todd Announces the Introduction of Todd Agriscience
Jun 1, 2024 09:00AM Hyundai Motor America Reports May 2024 Sales
Jun 1, 2024 09:00AM Beverly Hills MD Celebrates Its 10th Anniversary
Jun 1, 2024 09:00AM American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information
Jun 1, 2024 09:00AM Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
Jun 1, 2024 09:00AM Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
Jun 1, 2024 09:00AM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
Jun 1, 2024 09:00AM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
Jun 1, 2024 09:18AM 5 Ways BPO Services Can Improve Your Business Operations
Jun 1, 2024 09:18AM Amazed by these incredible facts about the yellow diamond
Jun 1, 2024 09:18AM Maximizing Efficiency: The Role of Content Moderation Services
Jun 1, 2024 09:18AM Wisconsin Top Performing Stocks
Jun 1, 2024 08:15AM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 1, 2024 08:15AM Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 08:15AM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
Jun 1, 2024 08:10AM Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual
Jun 1, 2024 08:05AM Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
Jun 1, 2024 08:05AM Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00AM Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Jun 1, 2024 08:00AM Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse
Jun 1, 2024 08:00AM James Avery Artisan Jewelry Opens New Store at Westover Marketplace
Jun 1, 2024 08:00AM Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
Jun 1, 2024 08:00AM TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting
Jun 1, 2024 08:00AM Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
Jun 1, 2024 08:00AM Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Jun 1, 2024 08:00AM Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
Jun 1, 2024 08:00AM BALEAF & SOJOS to host "Summer it up" summer fashion extravaganza!
Jun 1, 2024 08:00AM Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible patients
Jun 1, 2024 08:00AM KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Canc
Jun 1, 2024 08:00AM Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
Jun 1, 2024 08:00AM OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
Jun 1, 2024 08:00AM Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
Jun 1, 2024 08:00AM Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
Jun 1, 2024 08:00AM Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
Jun 1, 2024 08:00AM CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
Jun 1, 2024 08:00AM Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
Jun 1, 2024 08:00AM Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
Jun 1, 2024 07:55AM ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 1, 2024 08:15AM Gruvtype features de Buyer Products in Global Culinary Adventure with Free "Street, Beach & Sky" Preview Cookbook
Jun 1, 2024 07:10AM Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemo
Jun 1, 2024 07:00AM Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
Jun 1, 2024 07:38AM Horizon Wealth Donates $3 Million for Brazil's Post-Disaster Reconstruction
Jun 1, 2024 07:38AM Eurasian Capital Participates in the Third ICPAC Mediterranean Financial Summit: Exploring the Future Frontiers of Finance
Jun 1, 2024 06:20AM XAR and Salus Join Forces to Build zkLogin 'Hikari': The Final Step to Mass Adoption on Starknet
Jun 1, 2024 07:05AM Brandmydispo Continues to Innovate the Custom Mylar Bag Space
Jun 1, 2024 05:55AM ZEEKR Announces May 2024 Delivery Update
Jun 1, 2024 06:43AM Pamela Dowell's newly released "Saucey's Adventure" is a delightful adventure of a young unicorn in an unknown land.
Jun 1, 2024 05:42AM VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation
Jun 1, 2024 05:41AM SQSP (NYSE) REMINDER: BFA Law Reminds Squarespace Shareholders to Inquire About Ongoing Investigation into the $44 Buyout Offer
View Older Stories